14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 6.624 27 days ( -12.52 % )
Last Price $15.64 2.22 %
High/ Low $15.31 - $15.79 6.41%
Chg 7 Days 1.62 % $15.39 $15.64
Chg 30 Days 3.37 % $15.13 $15.64
Chg 12 mos 1,334.86 % $1.09 $15.64
Trend - 3 mos 14.59 % Width: 22.16 %
Trend - 12 mos 1,580.23 % Width: 74.29 %
Pred. range - 3 mos $15.71 - $19.19 0.437 % - 22.69 %
Pred. range - 12 mos $182.51 - $318.10 1,066.96 % - 1,933.92 %
Short MA avg 3 mos Sell Jun 17, 2024 - 4 days
Long MA avg 3 mos Buy May 13, 2024 - 28 days
Short/Long MA avg 3 mos Buy May 15, 2024 - 26 days
Short MA avg 12 mos Sell Jun 17, 2024 - 4 days
Long MA avg 12 mos Buy Jan 18, 2024 - 108 days
Short/Long MA avg 12 mos Buy Jan 24, 2024 - 104 days
Pivot Short Buy Apr 11, 2024 - 50 days
Bollinger Buy May 20, 2024 - 23 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Assembly Biosciences

Assembly Biosciences Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical tri... ASMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT